Ionic Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,650
| Closed | -$953K | – | 143 |
|
|
2024
Q3 | $953K | Hold |
9,650
| – | – | 0.17% | 41 |
|
|
2024
Q2 | $895K | Hold |
9,650
| – | – | 0.15% | 44 |
|
|
2024
Q1 | $916K | Sell |
9,650
-1,800
| -16% | -$171K | 0.3% | 40 |
|
|
2023
Q4 | $1.02M | Hold |
11,450
| – | – | 0.25% | 52 |
|
|
2023
Q3 | $836K | Hold |
11,450
| – | – | 0.2% | 63 |
|
|
2023
Q2 | $953K | Hold |
11,450
| – | – | 0.27% | 57 |
|
|
2023
Q1 | $873K | Hold |
11,450
| – | – | 0.25% | 60 |
|
|
2022
Q4 | $950K | Hold |
11,450
| – | – | 0.23% | 70 |
|
|
2022
Q3 | $908K | Hold |
11,450
| – | – | 0.12% | 107 |
|
|
2022
Q2 | $850K | Hold |
11,450
| – | – | 0.1% | 117 |
|
|
2022
Q1 | $1.03M | Buy |
+11,450
| New | +$1.03M | 0.12% | 130 |
|
|
2019
Q1 | – | Sell |
-30,000
| Closed | -$2.15M | – | 116 |
|
|
2018
Q4 | $2.15M | Buy |
+30,000
| New | +$2.15M | 0.22% | 21 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 141 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 198 |
|
|
2018
Q1 | – | Sell |
-121
| Closed | -$10K | – | 216 |
|
|
2017
Q4 | $10K | Hold |
121
| – | – | ﹤0.01% | 167 |
|
|
2017
Q3 | $10K | Sell |
121
-29,750
| -100% | -$2.46M | ﹤0.01% | 160 |
|
|
2017
Q2 | $2.31M | Buy |
+29,871
| New | +$2.31M | 0.12% | 70 |
|
|
2017
Q1 | – | Sell |
-1,821
| Closed | -$108K | – | 281 |
|
|
2016
Q4 | $108K | Buy |
+1,821
| New | +$108K | 0.01% | 173 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 290 |
|